Stock ATNM ACTINIUM PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Actinium Pharmaceuticals, Inc.

Equities

ATNM

US00507W2061

Real-time Estimate Cboe BZX
Other stock markets
 18:22:59 10/05/2024 BST 		5-day change 1st Jan Change
8.715 USD -2.08% Intraday chart for Actinium Pharmaceuticals, Inc. -2.90% +71.26%
05-07 Actinium Pharmaceuticals, Inc. Announces KOL Webinar to Highlight Recently Announced Iomab-ACT Trial with Leading FDA Approved Commercial CAR T-Cell Therapy Being Led by the University of Texas Southwestern CI
04-26 Actinium Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Actinium Pharmaceuticals, Inc. Appoints Lynn Bodarky as Chief Business Officer
CI
Actinium Pharmaceuticals, Inc. Appoints Caroline Yarbrough as Chief Commercial Officer
CI
Actinium Pharmaceuticals, Inc. Announces Executive Changes
CI
Actinium Pharmaceuticals, Inc. Announces Executive Appointments
CI
Genprex : Appoints Mark Berger Chief Medical Officer
MT
Actinium Announces Multiple Senior Leadership Appointments Including Chief Business and Commercial Officer, New Chief Medical Officer and Vice President, Patent and Legal Counsel
CI
Actinium Pharmaceuticals, Inc. Appoints Mark Kubik as Chief Business Officer
CI
Actinium Pharmaceuticals, Inc. Appoints Avinash Desai as Executive Vice President of Clinical Development, Operations and Medical Affairs
CI
Actinium Pharmaceuticals, Inc. Appoints Steve O’Loughlin as Chief Financial Officer
CI
Actinium Pharmaceuticals, Inc. Announces Resignation of Anil Kapur as Chief Commercial Officer, Effective November 29, 2019
CI
Actinium Pharmaceuticals, Inc. Appoints Niva Almaula as Chief Business Officer
CI
Actinium Pharmaceuticals, Inc. Appoints Mamata Gokhale as Vice President, Global Head of Regulatory Affairs
CI
Actinium Pharmaceuticals Appoints Cynthia Pussinen as Executive Vice President of Technical Operations and Supply Chain
CI
Actinium Pharmaceuticals, Inc. Appoints Qing Liang as Vice President and Head of Radiation Sciences
CI
Actinium Pharmaceuticals, Inc. Announces the Resignation of Nitya Ray as Executive Vice-President, Head of Product Development, Manufacturing and Supply Chain
CI
Actinium Pharmaceuticals, Inc. Appoints Robert N. Daly as Vice President, Head of Clinical Operations
CI
Actinium Pharmaceuticals, Inc. Appoints Members of Its Nuclear Medicine Clinical Advisory Board
CI
Actinium Pharmaceuticals, Inc. Appoints Jeffrey Chell to the Board of Directors
CI
Actinium Pharmaceuticals, Inc. Announces Management Appointments
CI
Actinium Pharmaceuticals, Inc. Appoints Jehan Rowlands as Vice-President, Head of Regulatory Affairs
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ATNM Stock
  4. News Actinium Pharmaceuticals, Inc.
  5. Insiders